ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.04
      -0.17%
      US Tech 100
      19,177.20
      0.01%
      Dow Jones
      39,062.29
      -0.13%
      Brent Oil
      83.805
      -0.45%
      Bitcoin
      61,281.38
      -0.86%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Amgen Inc (AMGN)

      7. Amgen Inc (AMGN) News

      AMGN

      Amgen (AMGN)

      Amgen Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AMGN
      DateTimeSourceHeadlineSymbolCompany
      2:09PMiHub NewswireFeaturedPOET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program
      06/14/20244:21PMPR Newswire (US)FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASENASDAQ:AMGNAmgen Inc
      06/12/20245:23PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AMGNAmgen Inc
      06/12/20249:00AMPR Newswire (US)AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024NASDAQ:AMGNAmgen Inc
      06/05/20244:00PMPR Newswire (US)AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
      06/05/20249:00AMPR Newswire (US)AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)NASDAQ:AMGNAmgen Inc
      06/04/20247:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/04/20247:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/04/20247:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/04/20247:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/04/20247:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/04/20247:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/04/20247:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/04/20247:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/04/20247:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/04/20247:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/04/20247:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/04/20247:22PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      06/03/20245:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMGNAmgen Inc
      06/03/20244:00PMPR Newswire (US)AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
      05/28/20249:00AMPR Newswire (US)AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024NASDAQ:AMGNAmgen Inc
      05/19/20245:15PMPR Newswire (US)NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPDNASDAQ:AMGNAmgen Inc
      05/16/20246:46PMPR Newswire (US)FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCERNASDAQ:AMGNAmgen Inc
      05/15/20246:45PMPR Newswire (US)AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024NASDAQ:AMGNAmgen Inc
      05/10/20244:02PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMGNAmgen Inc
      05/09/20247:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      05/09/20247:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      05/09/20247:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      05/09/20247:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
      05/09/20247:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
       Showing the most relevant articles for your search:NASDAQ:AMGN